HTDS

Hard to Treat Diseases Inc. HTDS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HTDS EHOS PBLA GBLX GSTC IRBS IMEXF MOBO XTXXF RGMP
6M 0.00 % 0.00 % -99.87 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -47.09 % 0.00 %
YTD 1 900.00 % 900.00 % -99.93 % -93.33 % -75.00 % 0.00 % 0.00 % 0.00 % 57.48 % 0.00 %
1Y 100.00 % 900.00 % -99.91 % -92.50 % -66.67 % 0.00 % 0.00 % -96.55 % 57.48 % 0.00 %
3Y 100.00 % -90.00 % -100.00 % -98.56 % -99.17 % 5 900.00 % -99.86 % -99.41 % -99.20 % -99.93 %
5Y 100.00 % 49 900.00 % -100.00 % -99.30 % -98.46 % 5 900.00 % -99.96 % -99.50 % -99.73 % -99.98 %
10Y -80.00 % 9 999 900.00 % -100.00 % -99.82 % -99.95 % 5 900.00 % -100.00 % -99.89 % -99.73 % -99.93 %
From the beginning -100.00 % -66.67 % -100.00 % -100.00 % -99.96 % 5 900.00 % -100.00 % -99.97 % -99.73 % -99.93 %

Dividend